Skip to content
Close
SEARCH
Let's Talk
Let's Talk

SOFTWARE
Discover Icon

Discover

Visualize rapid, validated insights through real-world data.
Activate Square

Activate

Streamline data preparation with guardrailed workflows.
Substantiate Square

Substantiate

Transform real-world data into decision-grade evidence.
Generate Square

Generate

Safeguard privacy and ensure utility with AI-driven technology.

SERVICES

PARTNERSHIPS

Aetion has entered into an agreement to be acquired by Datavant, a leading health data platform company.   Learn more → 

AdminOct 27, 2021< 1 min read

Synthetic Data Generation for Rare Disease Research

2021-10-27-Synthetic-Data-Generation-for-Rare-Disease-Research-1

Khaled El Emam, CEO, Replica Analytics, Jason Colquitt, CEO Across Healthcare

This webinar, presented by Dr. Khaled El Emam and Jason Colquitt, discusses the small data challenges of rare disease research and how synthetic data generation can help address these challenges.

 

 

Following the acquisition of Replica Analytics by Aetion, the generative AI technology previously known as Replica Synthesis is now Aetion® Generate and continues to create privacy-enhancing synthetic data.
Learn More

RELATED ARTICLES

AetionJun 3, 20257 min read

Real-World Evidence at Every Stage – How Aetion Powers the Drug Development Lifecycle

Natalie Schibell, MPH and Ashley Jaksa, MPH
Start Reading
AetionMay 29, 20254 min read

Built for Scientific Rigor: How Aetion Delivers Methodologically Defensible Real-World Evidence

Debra E. Irwin, PhD, MSPH, Amanda Kong, DrPH, and Natalie Schibell, MPH
Start Reading
Ashley Jaksa, MPHMay 27, 20253 min read

Reflections on SUSTAIN-HTA: Strengthening Process Readiness for Real-World Evidence in Health Technology Assessment

Real-world evidence (RWE) is becoming foundational in how health technology assessment (HTA) agencies evaluate therapeutic ...
Start Reading